Marta Mejías-Trueba

ORCID

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 17

Top Venues

Antibiotics (Basel, Switzerland)

Microbiology spectrum

Pharmaceutics

Innovation in aging

This page only lists publications with an associated author ORCID identifier.

Publications

Marta Mejías-Trueba, Alicia Gutierrez-Valencia, Silvia Llaves-Flores, Cristina Roca-Oporto, Marta Herrero, César Sotomayor de la Piedra, Luis Fernando López-Cortés, Nuria Espinosa
Long-term effectiveness, safety, and tolerability of doravirine in antiretroviral-experienced people with HIV in real life. Microbiology spectrum 12 (8) (2024)
Paula Del Valle-Moreno, Paloma Suarez-Casillas, Marta Mejías-Trueba, Pablo Ciudad-Gutiérrez, Ana Belén Guisado-Gil, María Victoria Gil-Navarro, Laura Herrera-Hidalgo
Correction: Del Valle-Moreno et al. Model-Informed Precision Dosing Software Tools for Dosage Regimen Individualization: A Scoping Review. Pharmaceutics 2023, 15 , 1859. Pharmaceutics 16 (6) (2024)
Ana Belén Guisado-Gil, Marta Mejías-Trueba, Germán Peñalva, Manuela Aguilar-Guisado, Jose Molina, Adelina Gimeno, Rocío Álvarez-Marín, Julia Praena, Claudio Bueno, José Antonio Lepe, María Victoria Gil-Navarro, José Miguel Cisneros
Antimicrobial Stewardship in the Emergency Department Observation Unit: Definition of a New Indicator and Evaluation of Antimicrobial Use and Clinical Outcomes. Antibiotics (Basel, Switzerland) 13 (4) (2024)
Marta Mejías-Trueba, Alicia Gutierrez-Valencia, Silvia Llaves-Flores, Cristina Roca-Oporto, Marta Herrero, César Sotomayor de la Piedra, Luis Fernando López-Cortés, Nuria Espinosa
Long-term effectiveness, safety, and tolerability of doravirine in antiretroviral-experienced people with HIV in real life. Microbiology spectrum 12 (8) (2024)
Marta Mejías-Trueba, Alicia Gutierrez-Valencia, Silvia Llaves-Flores, Cristina Roca-Oporto, Marta Herrero, César Sotomayor de la Piedra, Luis Fernando López-Cortés, Nuria Espinosa
Long-term effectiveness, safety, and tolerability of doravirine in antiretroviral-experienced people with HIV in real life. Microbiology spectrum (2024)
Paula Del Valle-Moreno, Paloma Suarez-Casillas, Marta Mejías-Trueba, Pablo Ciudad-Gutiérrez, Ana Belén Guisado-Gil, María Victoria Gil-Navarro, Laura Herrera-Hidalgo
Correction: Del Valle-Moreno et al. Model-Informed Precision Dosing Software Tools for Dosage Regimen Individualization: A Scoping Review. Pharmaceutics 2023, 15 , 1859. Pharmaceutics 16 (6) (2024)
Marta Mejías-Trueba, Alicia Gutierrez-Valencia, Silvia Llaves-Flores, Cristina Roca-Oporto, Marta Herrero, César Sotomayor de la Piedra, Luis Fernando López-Cortés, Nuria Espinosa
Long-term effectiveness, safety, and tolerability of doravirine in antiretroviral-experienced people with HIV in real life. Microbiology spectrum (2024)
Ana Belén Guisado-Gil, Marta Mejías-Trueba, Germán Peñalva, Manuela Aguilar-Guisado, Jose Molina, Adelina Gimeno, Rocío Álvarez-Marín, Julia Praena, Claudio Bueno, José Antonio Lepe, María Victoria Gil-Navarro, José Miguel Cisneros
Antimicrobial Stewardship in the Emergency Department Observation Unit: Definition of a New Indicator and Evaluation of Antimicrobial Use and Clinical Outcomes. Antibiotics (Basel, Switzerland) 13 (4) (2024)
Marta Mejías-Trueba, Aitana Rodríguez-Pérez, Carlos Hernández-Quiles, Manuel Ollero-Baturone, María Dolores Nieto-Martín, Susana Sánchez-Fidalgo
Feasibility of the Implementation of LESS-CHRON in Clinical Practice: A Pilot Intervention Study in Older Patients With Multimorbidity. Innovation in aging 7 (5) (2023)
Elena Montecatine-Alonso, Marta Mejías-Trueba, Walter Alfredo Goycochea-Valdivia, Estibaliz Chavarri-Gil, Cecilia M Fernández-Llamazares, Elisenda Dolz, José María Gutiérrez-Urbón, Carmen Gallego-Fernández, Jesús Llorente-Gutiérrez, María Victoria Gil-Navarro
Development of Antimicrobial Defined Daily Dose (DDD) for the Pediatric Population. Antibiotics (Basel, Switzerland) 12 (2) (2023)
Marta Mejías-Trueba, Aitana Rodríguez-Pérez, Carlos Hernández-Quiles, Manuel Ollero-Baturone, María Dolores Nieto-Martín, Susana Sánchez-Fidalgo
Feasibility of the Implementation of LESS-CHRON in Clinical Practice: A Pilot Intervention Study in Older Patients With Multimorbidity. Innovation in aging 7 (5) (2023)
Marta Mejías-Trueba, Aitana Rodríguez-Pérez, Emilio García-Cabrera, Carlos Jiménez-Juan, Susana Sanchez-Fidalgo
The Barriers to Deprescription in Older Patients: A Survey of Spanish Clinicians. Healthcare (Basel, Switzerland) 11 (13) (2023)
Elena Montecatine-Alonso, Marta Mejías-Trueba, Walter Alfredo Goycochea-Valdivia, Estibaliz Chavarri-Gil, Cecilia M Fernández-Llamazares, Elisenda Dolz, José María Gutiérrez-Urbón, Carmen Gallego-Fernández, Jesús Llorente-Gutiérrez, María Victoria Gil-Navarro
Development of Antimicrobial Defined Daily Dose (DDD) for the Pediatric Population. Antibiotics (Basel, Switzerland) 12 (2) (2023)
Elena Montecatine-Alonso, Marta Mejías-Trueba, Walter Alfredo Goycochea-Valdivia, Estibaliz Chavarri-Gil, Cecilia M Fernández-Llamazares, Elisenda Dolz, José María Gutiérrez-Urbón, Carmen Gallego-Fernández, Jesús Llorente-Gutiérrez, María Victoria Gil-Navarro
Development of Antimicrobial Defined Daily Dose (DDD) for the Pediatric Population. Antibiotics (Basel, Switzerland) 12 (2) (2023)
Cristina Villanueva-Bueno, Elena Montecatine-Alonso, Francisco Jiménez-Parrilla, María González-López, Silvia Manrique-Rodríguez, Francisco Moreno-Ramos, Carme Cañete-Ramírez, Elisenda Dolz, Ana García-Robles, José Manuel Caro-Teller, María Teresa Moral-Pumarega, Elena Bergon-Sendin, María Teresa Gómez-Trevecedo Calvo, Carmen Gallego-Fernández, Concepción Álvarez Del Vayo-Benito, Marta Mejías-Trueba, María Victoria Gil-Navarro, null Paediatric Antimicrobial Defined Daily Dose Study Group KiDDDs
Antimicrobial Defined Daily Dose in Neonatal Population: Validation in the Clinical Practice. Antibiotics (Basel, Switzerland) 12 (3) (2023)
Paula Del Valle-Moreno, Paloma Suarez-Casillas, Marta Mejías-Trueba, Pablo Ciudad-Gutiérrez, Ana Belén Guisado-Gil, María Victoria Gil-Navarro, Laura Herrera-Hidalgo
Model-Informed Precision Dosing Software Tools for Dosage Regimen Individualization: A Scoping Review. Pharmaceutics 15 (7) (2023)
Cristina Villanueva-Bueno, Elena Montecatine-Alonso, Francisco Jiménez-Parrilla, María González-López, Silvia Manrique-Rodríguez, Francisco Moreno-Ramos, Carme Cañete-Ramírez, Elisenda Dolz, Ana García-Robles, José Manuel Caro-Teller, María Teresa Moral-Pumarega, Elena Bergon-Sendin, María Teresa Gómez-Trevecedo Calvo, Carmen Gallego-Fernández, Concepción Álvarez Del Vayo-Benito, Marta Mejías-Trueba, María Victoria Gil-Navarro, null Paediatric Antimicrobial Defined Daily Dose Study Group KiDDDs
Antimicrobial Defined Daily Dose in Neonatal Population: Validation in the Clinical Practice. Antibiotics (Basel, Switzerland) 12 (3) (2023)

Marta Mejías-Trueba.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Marta Mejías-Trueba